In-vivo-and in-vitro evaluation of the 5 French neonatal gastric tonometer by Thorburn, Kentigern
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Title : In-vivo and in-vitro Evaluation of the 5 French 
Neonatal Gastric Tonometer 
Candidate: Thorburn K (THRKEN001) 
Degree: MMed in Paediatrics 
Supervisor : Professor V. Harrison 
Address for correspondence: 
Dr Kentigern Thorburn 
Department of Paediatric Intensive Care, 
Guy's Hospital, 
St Thomas Street 
London SE 1 9RT 
UK 
Tel. +44 171 955 2564 
Fax. +44 171 955 2563 
E-mail : k.thorburn@umds.ac.uk 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
DECLARATION 
I, Kentigern Thorburn, hereby declare that the work on which this thesis / 
dissertation is based is my original work ( except where acknowledgements indicate 
otherwise), and that neither the whole nor any part of it has been, is being, or is to 
be submitted for another degree in this or any other university. 
I empower the University of Cape Town to reproduce for the purpose of research 
either the whole or any portion of the contents in any manner whatsoever. 
Signature: 
Date: 
1 
Abstract 
Introduction - Gastrointestinal tonometry has been widely used in adult practice for the early detection of 
shock and multi-organ failure. Its application in paediatrics has been limited by unsuitably large tonometers 
and doubt about the accuracy of measurements when saline is used as a tonometric fluid / vehicle for carbon 
dioxide (CO2) equilibration. 
Objective - To evaluate the accuracy and reliability of the newly developed saline 5 French (5F) neonatal 
gastric tonometer. 
Study Design - (a) Direct in-vivo comparison of the 5F 0.9%saline tonometer (NST) with the recirculating 
gas tonometer (RGT) [the current reference standard in adult practice] in 10 Paediatric intensive care unit 
(PICU) patients, measuring tonometric PC02 (PtC02) and gastric intramucosal PC02 (PiC02). 
(b) In-vivo comparison of PiC02 measurements from two 5F tonometers in 10 PICU patients in unfed and 
fed state. 
@In-vitro comparison of reference PC02 to PtC02 values obtained using 0.9%saline and phosphate 
buffered saline in SF tonometers, and the RGT. 
Results - (a) Comparing the SF NST to RGT in 50 paired simultaneous measurements over PtC02 range 3.0 -
9.7kPa, the mean bias was -1.44kPa; limits of agreements (LOA) ±1.45kPa. The mean values of PtCOr 
derived gastric intramucosal pH (pHi) and PiC02-PaC02 difference differed significantly by -0.11 and 
+ 1.1 OkPa res pee ti vel y (p<O.0001). 
(b) 100 paired 5F NST measurements (50 fed/ 50 unfed) over PtC02 range 2.48-11. lkPa were assessed. No 
significant difference was observed in PtC02: mean difference(standard deviation) - unfed 0.05kPa 
(0.36) (p=0.36); fed 0.05kPa (0.42) (p=0.43). 
@20 consecutive measurements of PtC02 were obtained from the 5F NST, 5F phosphate buffered saline 
tonometer (PBST) and RGT at constant reference PCOi' s of 2.5, 5.0, 7.5, 10.0kPa. The 5F NST 
underestimated the reference PC02 by a mean bias of 58% (LOA ±20%); the 5F PBST by 6% (LOA 
±26%); while the RGT performed best with a mean bias of 5.7% and tight LOA ±1.5%. 
Conclusion - There are inherent problems in the methodology of the saline tonometry utilised in the 5F 
neonatal gastric tonometer. The use of the saline SF neonatal gastric tonometer to monitor gut perfusion in 
neonates and children should be interpreted with caution. Recirculating gas tonometry is the most accurate 
method of tonometry studied. 
• PiC02 = PtC02 X time-clependent factor 
• gastric intramucosal pH ~ pHi 
• pHi = 6.1 + log [arterial HC03} 
0.03 X PiC02 
• gastric intramucosal-arterial PC02 difference 
PiC02-PaC02 difference = PC02 gap 
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Background and Literature Review 
Gastrointestinal tonometry is a simple, minimally invasive technique of monitoring 
hepatosplanchnic perfusion which has been widely used in adult practice for the early detection of 
shock and multi-organ failure1-4 , and which may be a better prognostic indicator than either 
conventional biochemical parameters or haemodynamic indices4. Tonometry is based on the 
principle that, at equilibrium, the partial pressure of a diffusible gas, such as carbon dioxide (CO2), 
is the same in both the wall and the lumen of a viscus. Gastric tonometry can therefore measure 
the gastric intramucosal partial pressure of CO2 (PiC02) by measuring the intraluminal PC02. 
During steady state, PiC02 reflects the balance between CO2 production by gastric tissue and CO2 
removal (washout) by gastric/splanchnic blood flow. Decreases in splanchnic blood flow, with 
associated decreases in gut perfusion, can result in tissue hypoxia, anaerobic glycolysis, and 
tissue acidosis reflected in the intestinal and gastric mucosa by increases in tissue concentrations 
of Hydrogen ions (W) + CO2 5. 
Gastric tonometry involves the sampling of CO2 from a semi-permeable silicone balloon sited 
within the stomach on a blind-ending dual lumen nasogastric tube. Because of the easy diffusibilty 
of CO2, the balloon PC02 (PtC02) becomes equal to the gastric intramucosal PC02 (PiC02) after a 
period of equilibration1 3• The length of this period of equilibration depends on the vehicle (e.g. 
0.9%saline, air) used to carry the CO2, as well as the diffusion properties of the balloon itself1. The 
PiC02 may be used to calculate the gastric intramucosal pH (pHi) according to the Henderson-
Hasselbalch equation1 3 : pHi = 6.1 + log[arterial bicarbonate/(0.03 X PiC02)]. 
The pHi has been shown in many studies to hold prognostic value1-4 6-9 25 26. Unfortunately pHi 
relies on the often incorrect assumption that gastric mucosa! bicarbonate (HC03) always 
equilibrates the systemic arterial HC03 5. PiC02 is also influenced directly by the systemic arterial 
PC02 (PaC02). The gastric intramucosal-arterial PC02 difference (PiCOr PaC02 difference) is 
believed to be more accurate than pHi10 , as it is not changed by remote systemic acid-base 
metabolic disturbances. The PiCOrPaC02 difference is assumed to have the same prognostic 
value as pHi. 
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Gastric tonometry has traditionally utilised saline as the CO2 vehicle within the tonometer balloon, 
but due to inherent errors in the measurement of dissolved CO2, this method has been largely 
superseded by recirculating gas tonometry (utilises air as the CO2 vehicle) as the reference 
standard in adult practice3 11 12. Further critical analysis of the methodology of gastric tonometry is 
addressed later in the "Discussion" . It is better sited there as reference can be made to the present 
study as well. 
An adapted 7 French (7F) tonometer, originally designed for adult sigmoid placement, has been 
employed in children in place of the impractical larger standard adult 14 French (14F) tonometer. 
Only a few reports have evaluated gastric tonometry in paediatric practice (table 1 ), with the total 
number of paediatric cases studied in the literature being 228. All these studies have used saline 
as the CO2 vehicle and all have used the adapted 7F tonometer. 
Nearly all the paediatric tonometry studies have used pHi changes as their predictor of prognosis 
or outcome8 9 13 - 17. This is essentially for historical reasons. When these studies were performed, 
pHi was the accepted predictive marker in adult practice. Four of the six paediatric studies using 
pHi as a measure of outcome found it to hold predictive value8 9 13 15. In the studies of Hatherill M8 
(24 patients - septic shock) , Casado-Flores J9 (51 patients - post surgery, sepsis, trauma, 
respiratory) , and Krafte-Jacobs 8 13 (8 patients - septic shock) mean pHi values of < 7.30 - 7.32 
were predictive of poor outcome. Calvo C15 (30 patients - mostly post cardiac surgery) found a 
mean pHi < 7.30 at any stage to be predictive of serious haemodynamic complications, such as 
shock or cardiac arrest. 
Two studies, Duke TD16 (19 septic patients) and Wippermann CF17 (35 post cardiac surgery 
patients) , found pHi to be of no predicitve value. Duke TD16 found that neither the pHi values, nor 
the trends, predicted outcome. In fact, they found that raised lactate levels (> 3mmol/L) within the 
first 24 hours of admission a better marker of outcome. In the post cardiac surgery patient group of 
Wippermann CF17, the pHi values did not differentiate for patients developing post-operative organ 
dysfunction. 
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Only one 'enlightened' paediatric study used PiCOrPaC02 difference as a predictive marker -
Duke T18. All 20 paediatric patients were receiving extra-corporeal membrane oxygenation 
(ECMO) therapy during the study period (i.e. a highly selective and ill patient group) . 12 of the 20 
children died, 7 during ECMO and 5 thereafter (2 - 30 days post ECMO). Duke T18 found a high 
mean PiCOrPaC02 difference (23.6 mmHg; 95% confidence intervals:± 9.4 mmHg) predictive of 
mortality. Compared to this, survivors had a much lower mean PiCOr PaC02 difference (4.7 
mmHg; 95% confidence intervals: ± 5.4 mmHg). Animal and adult studies have shown PiCOr 
PaC02 difference values > 25 - 35 mmHg to indicate gut ischaemia
5 10
. The normal range for 
PiCOrPaC02 difference in adults is 3 - 10 mmHg 
10 35
. Future paediatric studies will undoubtedly 
concentrate on PiCOr PaC02 difference as a predictive index. 
Reinosa-Barbero F19 set out to establish a normal reference range for pHi in children. All the 17 
patients were in good health and underwent short minor surgical procedures. Normal pHi was 
reported as 7.35 ± 0.06 (mean I SD). 
Although 12 of the 20 ECMO patients in the study of Duke T18 were in the neonatal age group, the 
only study using a specifically neonatal patient group was that of Booker PD14. 24 neonates with 
congenital heart disease (age range: 3 - 57 days; mean weight 3.35kg) were studied before, 
during and after cardiac surgery with cardiopulmonary bypass. They concluded that neonates 
requiring aortic arch surgery may be at risk of gut hypoxia in the peri-operative period. They 
forwarded a pHi < 7.33 as indicating gut mucosal hypoxia. 
All the paediatric studies thus far have been observational studies, with none evaluating 
management strategies based on gastric tonometer measurements. No complications of gastric 
tonometry have been reported in any of these paediatric studies. 
It has recently been suggested that gastric tonometry may provide neonatologists with an "early 
warning" monitoring tool for the detection of necrotising enterocolitis (NEC)2° 21 . A case report by 
Hatherill M, Tibby SM et al 20 described a 2 day old term neonate (birth weight 3.2kg) with 
Hypoplastic Left Heart Syndrome whose persistently low pHi (< 7.32) predated the clinical onset of 
NEC by 4- 6 hours. 
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This has coincided with the development of a S French (external diameter 1.7mm) gastric 
tonometer (Tonometrics, Datex-Engstrom Division, Helsinki , Finland) , which because of its 
appropriately small size, is suitable for neonatal use. The new S French (F) gastric tonometer has 
the added advantage that it has a double lumen, so that along with the tonometer, it also contains 
an independent feeding/aspiration lumen and port. Thus negating the need for a separate 
nasogastric tube in these patients. The new SF neonatal device relies upon saline as the CO2 
vehicle. The small size of this SF gastric tonometer's balloon (1 cc) has made it technically 
impossible at this stage for recirculating gas tonometry to be utilised. Its size therefore 
necessitates the use of saline as the CO2 vehicle. It is marketed as a saline gastric tonometer. 
Table 1: Published results from Gastric tonometry in Paediatric practice 
Authors et al No. Patient group Comment/Prediction 
eatients 
Krafte-Jacobs B 13 8 Septic shock Non-survivors: mean pHi 7 .32 +/-0.18* 
1995 Paediatric Survivors: mean pHi 7.48 +/-0.07* 
Booker PD 14 24 Cardiac surgery Neonates undergoing aortic arch surgery at risk 
1996 Neonatal of gut hypoxia following cardiopulmonary by-pass 
Calvo C 15 30 Post surgery, sepsis pHi < 7.30 a predictor of haemodynamic 
1997 Paediatric complications 
Duke TD 16 19 Septic shock Neither absolute pHi nor trend in the first 
1997 Paediatric 48 hours was predictive of outcome 
Wippermann CF 17 35 Cardiac surgery pHi did not differentiate for patients who 
1997 Paediatric developed post-operative organ dysfunction 
Duke T 18 20 on ECMO High mean PiCOr PaC02 difference was a 
1997 Paediatric good predictor of death (23.6 mmHg +/-9.4t) 
Hatherill M 8 24 Septic shock Persistent pHi < 7.32 at 6 hours of PICU 
1998 Paediatric admission associated with poor prognosis 
Casado-Flores J 9 51 Critically ill At any time pHi < 7.30: predictor 
1998 Paediatric of mortality 
Reinosa-Barbero F 19 17 Minor surgery Normal pHi 7.35 +/-0.06* 
1998 Paediatric 
* mean! SD t mean I 95% confidence interval 
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Plate 1 shows the adult 14F tonometer, the 7F tonometer and the new 5F gastric tonometer 
In view of the potential application of this device to neonatal and paediatric practice, the accuracy 
and reliability of the 5F saline tonometer has been evaluated, in the first instance by direct in-vivo 
comparison with the current reference standard3 10 12 , the recirculating gas tonometer (Datex-
Ohmeda, Helsinki, Finland) , in a heterogeneous group of critically ill infants and children. Based on 
these findings, the sources of error in the measurement of PiC02 using this device, including the 
influence of gastric content, sampling technique, CO2 vehicle, and the CO2 analyser have been 
further investigated, both in-vivo and in an in-vitro model. Clarification of these issues may help 
standardise the interpretation of tonometric data before the 5F gastric tonometer becomes widely 
used in neonates and infants. 
Inches/ cm 
1ml syringe 
l 4F recirculating gas 
tonometer : 
Tonometer port/ lumen 
Feeding tube 
7F tonometer : 
( no separate feeding tube ) 
SF gastric tonometer : 
Loading/ sampling port 
Feeding tube 
Tonometer balloon 
Plate I : An adult l 4F gastric tonometer, a 7F to1-1ometer and the new SF gastric to
nometer 
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Patients and Methods 
The study was approved by the Guy's Hospital's Ethics Committee, and the Postgraduate 
Programmes Committee of the Faculty of Medicine of the University of Cape Town. 
The study comprised 3 stages: 
a) SF 0.9%saline tonometer vs recirculating gas tonometer in vivo. 
b) Dual SF 0.9%saline tonometers in vivo, both with and without enteral feeding . 
c) SF 0.9%saline tonometer, SF phosphate-buffered saline tonometer and 
recirculating gas tonometer vs known reference PC02 in vitro. 
The in-vivo components of the study were performed in the Caleb Paediatric Intensive Care Unit at 
Guy's Hospital in London :- 16 bed unit (with capacity to ventilate 16 patients) encompassing all 
aspects of medical , surgical and cardiac paediatric intensive care, including extra-corporeal 
membrane oxygenation (ECMO). 
Informed parental consent was obtained prior to the in-vivo components. 
Plate 1 illustrates the different gastric tonometers used in the study so an appreciation of their 
relative sizes may be gained (with a 1 ml syringe on the left for comparison) . 
All patients were monitored by routine gastric tonometry. The gastric tonometer, which is 
essentially a modified dual lumen nasogasfric tube, is inserted into the stomach via the nasogastric 
or orogastric route as one would insert a feeding tube. The length for insertion is measured by the 
same standard methods used for nasogastric or orogastric feeding tubes. Confirmation of 
placement in the stomach is by the usual aspiration of acidic gastric contents and/or radiological 
confirmation. No analgesia, anaesthesia nor sedation is required for the insertion or monitoring of 
there tonometers. In fact the separate feeding/aspiration lumen of the SF gastric tonometer 
functions as the nasogastric or orogastric tube for the patient. 
The design of this study evaluated the new SF neonatal gastric tonometer and was not primarily 
involved in determination of clinical outcome. 
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a) SF 0.9%Sa/ine tonometer (NST) vs recirculating gas tonometer (RGT) in vivo. 
Ten intubated and ventilated children, median age 13 months (range 1 day - 6 years) and median 
weight 10.2 kg (range 4.1 - 20 kg) , were enrolled after stabilisation in the paediatric intensive care 
unit (PICU) . Their diagnoses included meningococcal disease (n=4) , pneumonia (n=2) , cardiac 
surgery (n=3) , and head injury (n=1). Patients were haemodynamically stable and had no active 
interventions nor ventilatory changes performed during the 6 hour study period. In each patient a 
SF NST and a 7F RGT were placed in the stomach by the orogastric route, inserted as one would 
insert an orogastric feeding tube. The ends of the two tonometers were tethered together to ensure 
that the silicone balloons were sited in the same area in the stomach, and their position was 
confirmed radiologically prior to commencement of the study. 
The 7F RGT was used in place of the significantly larger standard 14F adult RGT because of the 
small size of our patients. The 7F RGT and the 14F RGT have been shown to behave similarly 
and give the same measurements when compared with each other31 . 
Plate 2 illustrates the positions and size of the two tonometers in one of the study patients. 
All patients, when not enterally fed , received sucralfate but not histamine-2 (H-2) antagonists. 
The balloon of the NST was loaded according to the manufacturer's instructions with 1 ml normal 
sal ine. After a 60 minute equilibration period the first 0.4ml was aspirated and discarded to account 
for dead space. Gastric intramucosal CO2 (PiC02) , equivalent to the tonometer CO2 (PtC02) , was 
measured in the remaining 0.6ml aspirate, using the IL BGE blood gas analyser (Instrumental 
Laboratories, Lexington, USA ). A strict anaerobic sampling technique was maintained to minimise 
CO2 loss. Meticulous care was taken not to introduce any air into the sample and to remove any 
immediately. All samples were analysed within 2 minutes of aspiration. The same person took all 
the samples. All saline PtC02 measurements were then corrected by the 60 minute time-
dependent factor of 1.13 recommended by the manufacturer22 to allow for incomplete equilibration. 
Full equilibration for normal saline takes 90 minutes22 . The manufacturer has derived time-
dependent factors by directly measuring the PC02 within the tonometer balloon over time against 
known external PC02 values. 
Plate 2: Xray showing a 7F and a 5F tonometer ( contrast enhanced) 
in-situ in one of the study patients. 
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In the case of the RGT, a specialised capnograph (Tonocap, Datex, Helsinki , Finland) utilising 
infrared absorbence spectrometry was used to measure the PC02 of the 6ml of air it re-circulated 
through the tonometer balloon, following a 10 minute dwell time (i.e. equilibration period). No time-
dependent factor is required for RGT. The average RGT measurement was taken for the 60 
minute equilibration period required for the NST. 
Five simultaneous paired measurements, each following a 60 minute equilibration period, were 
taken in each patient. With each paired tonometer reading , an arterial blood gas was taken 
anaerobically for corresponding arterial CO2 (PaC02) and serum bicarbonate (HC03) levels, and 
measured by the same blood gas analyser. All saline and blood samples were temperature 
corrected when processed in the blood gas analyser. ·A total of 50 paired tonometer readings were 
taken. Gastric intramucosal pH (pHi) and the PiCOrPaC02 difference (PC02 gap) were derived 
from the measured PiC02 values using each modality (NST and RGT). 
(b) Dual SF 0.9%saline tonometers (NST) in vivo, before and after enteral feeding. 
A further 10 intubated and ventilated PICU patients were studied, median age 3.25months (range 
1 day - 11 months) ; median weight 3.5kg (range 2.5 - 5.5kg). Diagnoses included cardiac surgery 
(n=5) , bronchiolitis (n=3) , pneumonia (n=1 ), and pre-operative hypoplastic left heart syndrome 
(n=1 ). Two SF NST's with their ends tethered together were placed in the stomach by the 
orogastric route as previously described. 
Plate 3 illustrates the position and size of the two 5F NST's in one of the study patients. 
Ten simultaneous paired measurements were taken, each following a 60 minute equilibration 
period, 5 with the patient unfed and 5 after the institution of enteral feeding - median feed volumes 
2ml/kg/hour (range 1 - 4ml/kg/hour). Measurements were taken on average 8 hours (range 6-12 
hours) after feeding had been established. A total of 100 paired PiC02 measurements were taken 
(50 unfed and 50 fed) , along with the corresponding arterial blood gas parameters, and corrected 
by the time equilibration factor as described. 
Plate 3: Xray demonstrating two 5F tonometers ( contrast enhanced) 
in-situ in one of the study patients. 
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c) 5F 0.9%Sa/ine tonometer (NST), 5F phosphate-buffered saline tonometer (PBST) and 
recirculating gas tonometer (RGT) vs reference PC02 in vitro. 
A sealed equilibration chamber containing 0.9% Saline was maintained at 37°C. CO2 was bubbled 
through the saline and kept at constant reference PC02's of 2.5, 5.0, 7.5 and 10.0 kPa. The PC02 
was monitored and maintained at these levels using a Paratrend 7 probe (Biomedical Sensors, 
High Wycombe, UK) in the chamber saline. 
Prior validation of the Paratrend 7 probe against known concentrations of CO2 in saline using in-
line capnography (Ultima, Datex-Ohmeda, Helsinki, Finland) gave an equation of : 
y = 0.91x + 0.49 (r2 = 0.99). 
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Figure 1 : Correlation plot of capnographic PC02, corrected for humidification , against the PC02 measured 
by the Paratrend 7 in the equilibration chamber saline 
The Paratrend 7 probe is a multi-parameter intra-arterial sensor (MPIAS) that allows continuous 
accurate and reliable intra-arterial monitoring of temperature, pH, P02 and PC02. A signal light 
beam is sent down optic fibres and a stainless steel mirror at its tip reflects the altered light beam 
back up the optic fibres to the detectors - i.e. a miniature spectrophotometer. The CO2 sensor is 
enclosed within a gas-only permeable membrane and encapsulated within is a bicarbonate 
solution containing phenol red dye as an indicator. CO2 diffuses across the membrane and alters 
the pH of the solution. The PC02 is measured by measuring the absorbency of green light by the 
red dye. 
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Two 5F neonatal gastric tonometers and a standard adult 14F RGT were positioned in the saline 
chamber with their distal ends tethered together. Normal saline (0.9%) was utilised as the CO2 
collection vehicle in the first 5F tonometer (NST) and phosphate-buffered saline in second 5F 
tonometer (PBST). The PBST fluid contained NaH2P04 44mmol and Na2HP04 6mmol, adjusted to 
pH 6.0 (saline has pH 6.2) . The 14F RGT was used as this tonometer is the established reference 
standard in adult practice31112. 
Figures 2 and 3 illustrate the in-vitro study apparatus. 
Loading, sampling and PtC02 analysis for saline and gas tonometers was as previously described. 
Twenty consecutive measurements of PtC02, each following a 60 minute equilibration period , 
were obtained from the NST, PBST, and the RGT, with a constant reference PC02 of 2.5 kPa in 
the saline chamber as determined by the Paratrend 7 sensor. This process was repeated tor 
equilibration chamber I bath saline reference PC02 levels of 5.0, 7.5, and 10kPa respectively . All 
NST and PBST PC02 readings were corrected by the manufacturer's (Tonometrics) 60 minute 
time-dependent factor of 1.13 and 1.11 respectively22. With each PtC02 measurement, a sample 
of the bath saline was anaerobically aspirated and PC02 was measured by the same blood gas 
analyser. The bath saline PC02 values were not corrected, as the time-dependent factors relate to 
equilibration periods of the saline tonometers only. 
Statistical Analysis : 
In-vivo: Data were analysed using Student's paired t-test, Mann-Whitney U test and the Chi 
square test. Comparison of recirculating gas tonometry with saline tonometry was by the Bland 
and Altman method23. 
In-vitro: Data were analysed by linear regression and the Bland Altman method23, and were 
logarithmically transformed where appropriate. 
Paratrend 7 probe 
Figure 2 : In-vitro study apparatus - close-up view 
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Results 
a) 5F 0.9%Sa/ine tonometer (NST) vs recirculating gas tonometer (RGT) in vivo. 
Figure 4 illustrates the Bland-Altman plot of PiC02 for the RGT (reference standard) against those 
simultaneously measured by the SF NST over the range 3.0 - 9.7kPa. The figure shows poor 
agreement between the two methods, with a wide scatter across the range measured (Mean bias: 
-1 .44kPa; 95% confidence interval of mean bias: -1.65 to -1 .23; with limits of agreement (LOA) 
±1.45kPa). 
0.5 
0 
0 -- --· -- -· -- --· -·- -· -- --· --- -· -- --· --- -· -- Zero bias 
<S>o Mean Bias: -1.44kPa 
0 GI> Oo o 95%CI: -1.65 to -1.23 
UI 
°'g -0.5 
.s::. 
ai 
E -1 ~\o O 
O 
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5i 1 5 - - - .o. - -h" o.o -o. ·o· - - - - - - - . Cl) - • C, 
i ·2 ~ ~o 08 ~ Oo 00 C -2.5 0 
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Figure 4 : Bland Altman plot of gastric intramucosal PC02 (PiC02) for the recirculating gas tonometer 
(RGT) against the SF 0.9%saline tonometer (NST). 
95%CI = 95% confidence interval of the mean bias LOA = limits of agreements 
Table 2 shows the mean [standard deviation/SD] tonometric PC02 (PtC02 = PiC02) along with its 
derived pHi and PiCOr PaC02 difference (PC02 gap) for RGT and NST. Comparing RGT to NST, 
the mean values differed significantly by: PtC02 + 1.44kPa; pHi -0.11 ; PC02 gap + 1.1 OkPa. Both 
tonometers did however demonstrate similar increased or decreased trends in their PiC02 in 95% 
(38/40) of cases. 
Table 2 : Comparison of tonometer PCOi (PtC02), their derived pHi and PiC02-PaC02 difference 
(PC02 gap) between the recirculating gas tonometer (RGT) and SF 0.9%saline tonometer (NST) -
shown as: mean[± 1 standard deviation] 
PtC02 (kPa) 
pHi 
PC02 gap (kPa) 
RGT 
6.38 [±1.67] 
7.26 [±0.13] 
1. 79 [±1 .20] 
NST 
4.94 [±1 .28] 
7.37 [±0.12] 
0.73 [±0.70] 
Difference 
1.44 [±0.74] 
0.11 [±0.04] 
1.06 [±1.01] 
p Value 
0.0001 
0.0001 
0.0001 
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b) Dual 5F 0.9%saline tonometers (NST) in vivo, before and after enteral feeding. 
In the unfed state, over the range of tonometric PiC02 2.42 - 11 .1 kPa (median 4.73 kPa) , the 
mean difference between the two saline tonometers was 0.05 kPa (SD 0.36kPa) . In the fed state 
over the range 2.48 - 8.71 kPa (median 4.71 kPa), the mean difference between the tonometers 
was 0.05 kPa (SD 0.42kPa). There was no significant difference noted between the tonometers in 
either the unfed or fed state (p=0.36 and p=0.43 respectively) . Both tonometers followed the same 
increased or decreased trend in their PiC02 in 75% (30/40) of cases in the unfed state, and in 68% 
(27/40) of cases in the fed state ( Chi2 p = 0.82 ). 
c) In-vitro: 5F 0.9%Saline tonometer (NST), 5F phosphate-buffered saline tonometer (PBST) 
and recirculating gas tonometer (RGT) vs reference pC02 . 
The performance of the 3 tonometers is shown in figures 5, 6, 7, 8; table 3 and table 4. 
Figure 5 shows a correlation plot of reference PC02 against PtC02 of RGT, PBST, NST and the 
Bath saline. Linear regression of PtC02 values derived from each modality yields equations of 
y = 0.97x-0.13 (r2 = 0.99) for the RGT, y = 0.78x+0.82 (r2 = 0.97) for the PBST, 
y = 0.59x+0.18 (r2 = 0.98) for the NST, and y = 0.61x+0.25 (r2 = 0.97) for Bath saline. 
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Figure 5 : Correlation plot of reference PC02 against the recirculating gas tonometer (RGT), 
SF phosphate buffered saline tonometer (PBST), SF 0.9%saline tonometer (NST) and bath saline (Bath) 
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Figures 6, 7 and 8 illustrate the Bland Altman plots for RGT, PBST and NST respectively against 
the reference PC02 values. 
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Figure 6 : Bland Altman plot of PtC02 of RGT against the reference PC02 values 
Figure 6 shows good agreement between the PtC02 for RGT and the reference PC02, noting that 
the y-axis (difference between RGT and reference PC02) is in units of only 0.1 kPa. 
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Figure 7 : Bland Altman plot of PtC02 of PBST against the reference PC02 values 
Figure 7 shows initial moderate agreement between PBST and the reference PC02, with 
increasing underestimation and widening scatter as the reference PC02 increases past 5kPa. 
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Figure 8 : Bland Altman plot of PtC02 of NST against the reference PC02 values 
Figure 8 shows poor agreement, progressively worsening negative bias and scatter of NST PtC02 
measurements as the reference PC02 increases. 
Both PBST and especially NST demonstrate increasing underestimation/negative bias of PtC02, 
along with widening limits of agreements (LOA), with increasing reference PC02 levels (table 3) . 
The corresponding measurement of the bath saline PC02, measured simultaneously with the 
tonometric PtC02 's, was also consistently lower than the reference PC02, and very similar to the 
performance of NST (figure 5 and table 3) . 
Table 3 : Mean PC02, mean bias, limits of agreement (LOA), in kPa, of each tonometer and Bath saline 
for each of the reference PC02 groups and overall 
pC02 group 2.5 kPa 5 kPa 7.5 kPa 10 kPa Overall 
RGT (mean) 2.36 4.67 7.14 9.63 5.96 
Mean Bias -0.15 -0.34 -0.37 -0.38 -0.31 
LOA± 0.17 0.11 0.22 0.22 0.25 
PBST (mean) 2.84 4.67 6.55 8.7 5.69 
Mean Bias 0.33 -0.34 -0.96 -1.31 -0.57 
LOA± 0.33 0.6 0.68 0.94 1.4 
NST (mean) 1.68 3.16 4.6 6.15 3.95 
Mean Bias -0.83 -1 .85 -2 .91 -3.86 -2.36 
LOA± 0.22 0.35 0.39 0.63 2.27 
Bath (mean) 2.04 3.43 4.84 6.31 4.15 
Mean Bias -0.47 -1 .58 -2.67 -3.7 -2.11 
LOA± 0.21 0.29 0.34 0.72 2.41 
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After logarithmic transformation to compensate for the heteroscedasticity (lack of uniformity of 
variance), the overall relative bias of the NST, PSST and RGT compared to the reference PC02 
values is shown in table 4, expressed as percentages for better clarity. 
Table 4 : Mean bias, 9S% confidence interval of mean bias (9S% CD, limits of agreement (LOA) 
of the tonometric PC02 (PtC02) measurements from the recirculating gas tonometer (RGT), SF phosphate 
buffered saline tonometer (PBST) and SF 0.9%saline tonometer (NST) compared to the reference PC02 over 
the entire range of values 
RGT 
PBST 
NST 
Mean Bias 
5.7% 
6% 
58.6% 
95%CI 
5.2 to 6.2% 
3.0 to 9.0% 
56.4 to 60.8% 
LOA 
± 1.5% 
±26% 
±20% 
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Discussion 
The principle of tonometry was first reported in 1959 by Boda and Muranyi who estimated PaC02 
levels in ventilated children with polio by measuring intraluminal gastric CO2 levels24 . Since then 
the further application and clinical development of this technique has almost exclusively been in 
adult patients. Gastric tonometry has been widely used in adult practice to monitor the adequacy of 
hepatosplanchnic perfusion, using parameters such as PiC02, pHi or the PiCOrPaC02 difference, 
as indicators of shock, organ failure or mortality6 10 25 26. 
Recently adult physicians have begun to express concern over the use of 0.9%saline as the 
vehicle for tonometric studies, and phosphate buffered saline has been used in some centres to 
decrease the loss of dissolved C0211 22 27. It was also noted that underestimation of PC02 in saline 
varied with the type of blood gas analyser used 11 22 27 28• For these reasons gastric tonometry in 
adult practice is changing from the saline vehicle to the recirculating gas technique3 11 12 29. 
Tonometry in infants and children has been limited by the size and construction of the available 
devices and all studies have used 0.9%saline in the balloon. It has been suggested that gastric 
tonometry may be used to detect the onset of necrotising enterocolitis in neonates20 21 . For this 
reason the development of a 5F tonometer suitable for neonatal use is particularly welcome. This 
study sought to evaluate this neonatal 5F saline-based tonometer, both in-vivo and in an in-vitro 
model, in order to clarify the areas of difficulty highlighted by the adult experience30. Whether 
feeding influences their accuracy and reliability was also investigated. 
In vivo (a) using the RGT as the reference standard, it was shown that NST consistently 
underestimates the PiC02 across the studied range (3.0 - 9.7kPa) by a mean bias of 1.44kPa 
(LOA ±1.45kPa). Accordingly the PiCOrPaC02 difference and pHi, which are derived from the 
PiC02, were both significantly different between RGT and NST (p=0.001). This is important to note 
since it is tonometer-derived pHi that has been shown to hold prognostic value7 8 9 26. Thus creating 
confusion as to which of the methods should be used for prognostication. 
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Whilst NST underestimated PiC02 compared to RGT, they both still paralleled the same trends in 
PC02. Therefore it might be more appropriate to follow trends in PiC02 rather than absolute values 
when utilising the NST. 
Several factors may play a role in the apparent lack of accuracy in the measurement of PiC02 
using the SF neonatal NST. Dissolved CO2 can be lost during aspiration from the tonometer 
balloon, especially if air is introduced into the sample. The natural instability of CO2 in the saline 
medium allows for it to be easily and readily lost from solution. There is systematic 
underestimation of saline PC02 by the blood gas analyser. This may be due to calibration 
problems, insensitivity of the CO2 probe to saline PC02, or the loss of dissolved CO2 as the 
sample passes through the analyser. It was therefore attempted to isolate some of these 
components in our further evaluation of the device. 
In vivo (b) two saline SF neonatal tonometers were compared using an identical technique, to 
minimise the influence of the individual variation of each tonometer due to CO2 loss. Recently 
presented adult work has suggested there may be a large discrepancy (in excess of 2.SkPa) 
between simultaneous measurements from two tonometers in the same stomach31 . In this study 
population there was no significant difference between simultaneous NST measurements either in 
the unfed (mean difference O.OSkPa, SD 0.36kPa; p=0.36) or fed (mean difference O.OSkPa, SD 
0.42kPa; p=0.43) state. Feeding did not appear to affect the two tonometers' ability to mirror each 
others trends in PiC02 (Chi2 = 0.82). 
There has also been controversy over the influence of gastric contents and H-2 antagonists on the 
measurement of PiC02 32-36. It is not our unit 's usual policy to place children who are nil per mouth 
on H-2 antagonists because of the perceived risk of nosocomial infection37 38. Their mandatory use 
is still contested32 36. The study patients were given sucralfate, which does not interfere with the 
interpretation of pHi measurements39 40 . 
25 
In vitro (c) it was demonstrated that the best method of tonometry studied is RGT (mean bias -
5.7% LOA ±1.5%). NST underestimates PtC02 by a large bias of 58% (LOA ±20%). It may be 
inferred that even with meticulous attention to sample handling the low stability of CO2 in saline 
allows for easy loss from CO2 in the sample. Although the considerable bias in the NST 
measurement of PtC02 is specific to the IL BGE blood gas analyser, other studies have 
demonstrated that other types of blood gas analyser may perform even less accurately with 0.9% 
sal ine22 27 • 
Both the directly aspirated bath saline PC02 and the NST PtC02 were underestimated by a similar 
magnitude (figure 5 and table 3) . This finding infers that this systematic error is related to CO2 loss 
from the sample, and/or underestimation by the blood gas analyser, rather than the physical 
properties of the SF neonatal tonometer. 
It has been suggested that use of a phosphate buffered saline vehicle allows greater CO2 solubility 
and stability, thus minimising CO2 loss11 22 27 28 . Although PBST only underestimated by a mean 
bias of 6%, the limits of agreement were even larger than NST (26% vs 20%), and considerably 
more than RGT (1 .5%). In view of the difficulties involved in using PBST, such as preparation time 
and degradation of the solution, and its poor performance in-vitro, one may suggest that the 
phosphate buffered saline has little practical advantage over normal saline. 
In comparison to both the NST and the PBST, RGT demonstrates both a small bias (5.7%) and 
tight limits of agreement (±1.5%), reiterating the adult experience that recirculating gas tonometry 
does not suffer from the problems encountered in saline tonometry111229. This may also be due to 
the advantages of the in-built capnograph, which is reliable, easily recalibrated and accurate. The 
standardisation of these specially adapted capnographs (Tonocap monitors) has also allowed 
tonometric data from different centres to be comparable and baseline values to be set in adult 
practice. 
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Possible other solutions to overcome the problems in the saline tonometric technique are :-
1 . The specific calibration of a specially designated blood gas analyser to be used solely for 
measuring saline samples. 
2. The calculation (from linear regression equations) of correction equations specific to each 
blood gas analyser being used, to account for its inherent underlying bias. 
Both of these solutions are essentially impractical. 
3. Its use to monitor trends within the individual patient, rather than absolute or one-off values. 
Although the SF gastric tonometer was designed for use in neonates, it is also suitable for all ages 
and sizes. The size of the tonometer balloon does not affect its accuracy 11 22 31 . 
The SF gastric tonometer has many advantageous features:-
lts size allows for tonometric monitoring of patients from 800 - 900grams body weight upwards; 
It can easily be placed in the stomach by the nasogastric route (unlike the larger tonometers which 
require orogastric placement); 
Its separate feeding/aspiration lumen and port serves as a conventional nasogastric tube; 
It is made from polyurethane, which allows it to left in-situ for an extended period. 
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Conclusion : 
This study has highlighted the problems inherent in the methodology of saline tonometry with the 
5F neonatal gastric tonometer. It has shown that PiC02, and the derived variables pHi and PiCOr 
PaC02 difference, differ considerably depending on the method of tonometry. 
Although recirculating gas tonometry is presently the most reliable and accurate method of 
tonometry, it is currently unavailable for neonates and small infants. Until this technology is 
developed, the use of saline tonometry to monitor gut perfusion in neonates or children should be 
interpreted with caution. 
Indeed, it suggests that the saline technique, which is utilised in these 5F neonatal gastric 
tonometers, makes the interpretation and comparison of tonometric data from different centres 
virtually impossible, seeing that each centre's PiC02 results/measurements will be specific to their 
unit's blood gas analyser. 
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Data (a) In-vivo RGT-NST 
NST uncor cNST RGT PaC02 art HC03 Art pH 
1 
1 4.13 4.67 5.4 4.21 20.6 7.35 R.D. 
2 4.29 4.85 5.7 4.5 21 .9 7.36 Meningococcal disease 
3 4.44 5.02 7.3 5.24 19.2 7.29 
4 3.79 4.28 6 3.4 16.3 7.41 
5 3.04 3.44 4.5 3 13.2 7.37 6 yrs old/ 19.8kg 
2 
6 5.73 6.47 7.6 7.34 30.4 7.34 T.N. 
7 4.97 5.62 7 5.78 24.9 7.36 Pneumonia 
8 8.12 9.18 8.9 6.75 24.3 7.28 Sickle Cell 
9 4.35 4.92 7.1 5.26 24.1 7.39 
10 4.23 4.78 6.4 4.63 23.7 7.44 2 yrs old / 17kg 
3 
11 5.6 6.33 7.7 4.15 22.5 7.46 J.B. 
12 3.56 4.02 6.2 4.34 23.1 7.45 Meningococcal disease 
13 3.7 4.18 5.2 3.74 22.5 7.51 
14 3.3 3.73 5.1 3.19 19.4 7.51 
15 4.11 4.64 6.8 6.31 22.1 7.27 10 months old / 10kg 
4 
16 4.72 5.33 7 4.51 18.4 7.34 C.P. 
17 4.86 5.49 7.6 4.36 17.6 7.34 Meningococcal disease 
18 4.35 4.92 6.9 4.58 18.8 7.34 
19 4.3 4.86 6.4 4.5 17.8 7.33 
20 4.19 4.73 5.9 3.86 16.4 7.36 9 months old/ 10.2kg 
5 
21 3.74 4.23 5.2 4.69 29.6 7.53 J.A. 
22 3.02 3.41 4.6 3.65 23.2 7.53 Pneumonia 
23 3.82 4.32 5.6 5.73 23.9 7.35 ALL 
24 4.19 4.73 6.8 6.04 26.3 7.37 Sepsis 
25 6.21 7.02 8.6 6.29 27.5 7.37 3 yrs old / 14.9kg 
6 
26 5.03 5.68 8 5.84 18.2 7.22 Y.P. 
27 5.58 6.31 8.5 5.52 17.3 7.22 Meningococcal disease 
28 5.89 6.66 9.2 5.15 16.5 7.24 
29 5.43 6.14 9.5 6.24 17.2 7.17 
30 6.3 7.12 9.6 6.67 17.8 7.15 16 months old / 10.1 kg 
7 
31 2.89 3.27 4.3 4.16 24.3 7.5 J-K. C. 
32 3.55 4.01 4.8 4.05 20.3 7.43 TGA Switch 
33 3.63 4.10 5.2 3.98 21 7.45 
34 3.76 4.25 5.4 4.51 25 7.47 
35 3.75 4.24 5.4 3.75 19.4 7.44 1 day old/ 4.1 kg 
cNST = time-dependent factor corrected values 
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Data (a) In-vivo RGT-NST 
NST uncor cNST RGT PaC02 art HC03 Art pH 
8 
36 2.76 3.12 3.7 3.06 20.9 7.44 T.C. 
37 2.7 3.05 3.6 3.46 17 7.42 Rastelli procedure 
38 3.13 3.54 3.8 2.97 15.5 7.45 P A/VSD/MAPCAS/PDA 
39 3.31 3.74 4.7 3.51 15 7.36 
40 2.91 3.29 4.4 3.62 16 7.38 2 yrs old / 10.4kg 
9 
41 6.26 7.07 8.4 4 20 7.43 K.Y. 
42 5.47 6.18 8.1 4.14 20.9 7.41 Head Injury 
43 5.63 6.36 8.4 4.84 20.3 7.35 Leg# 
44 5.17 5.84 8.3 4.75 20.5 7.36 
45 5.09 5.75 8.3 3.77 19 7.43 5 yrs old/ 20kg 
10 
46 5.24 5.92 6.4 5.37 16.1 7.3 O.M-J . 
47 3.47 3.92 4.3 3.78 19.9 7.45 Fallots Repair 
48 3.26 3.68 3.9 3.86 19.5 7.43 Junctional Tachycardia 
49 3.65 4.12 4.9 4.25 18.7 7.37 Pleural Effusions 
50 3.82 4.32 6.2 4.41 18.1 7.34 10 months old/ 7.3kg 
cNST = time-dependent factor corrected values 
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Data (b) In-vivo NST-NST (kPa) 
cNST 1 cNST2 PaC02 Patient cNST 1 cNST2 PaC02 
1 3.1 2.9 4.28 H.K. 3.1 2.68 4 1 week old 
2 3.06 2.94 4.19 Coarctation 3.02 3.01 4.03 3kg 
3 3.48 2.72 3.86 Repair 2.92 2.48 4.4 
4 2.81 2.42 4.6 2.81 2.64 4.28 
5 2.82 2.59 4.68 NPM 3.14 3.02 4.76 FED 
6 4.57 4.47 5.53 R.S. 5 4.2 4.69 4 months old 
7 5.17 4.85 6.01 Fallots Repair 4.19 4.11 4.37 4kg 
8 4.82 4.67 5.9 CHARGE 4.05 4.25 4 
9 5.46 5.11 7.42 4.36 4.06 4.72 
10 6.17 6 7.9 NPM 5.27 5.41 6.1 FED 
11 6.02 5.65 6.94 R.L. 5.02 4.96 6.09 2 months old 
12 5.22 5.6 7.1 TAPVD 4 4.82 6.9 3.1kg 
13 5.16 6.03 6.07 RSV+ 4.69 4.6 6.91 
14 3.65 3.84 6.1 4.75 3.64 6.75 
15 4.55 4.08 6.77 NPM 4.47 4.11 7.18 FED 
16 4.45 3.74 5.76 A.M. 4.69 4.37 5.12 1 day old 
17 3.66 4.24 6.8 Hypoplastic 4.3 4.63 4.25 2.5kg 
18 3.77 3.52 3.89 Left Heart 4.55 4.73 6.1 
19 3.89 3.92 5.39 2.48 2.73 5.87 
20 4.11 4.16 5.35 NPM 4.08 4.16 5.87 FED 
21 4.84 4.84 5.12 M.K. 6.44 6.34 4.8 2 months old 
22 5.39 6.07 5.54 AVSD Repair 5.97 6.37 6.02 2.7kg 
23 4.25 4.23 5.03 LAI/DextraCardia 4.57 4.39 4.53 
24 3.58 3.86 4.03 3.52 3.9 5.4 
25 3.89 3.93 4.26 NPM 3.61 3.83 4.3 FED 
26 3.91 4.76 5.17 D.L. 4.46 5.05 6.28 7 days old 
27 4.77 4.42 5.23 Mitral Stenosis 5.53 5.04 5.56 2.87kg 
28 4.55 4.64 4.9 Valve Repair 6.71 6.22 6.35 
29 4.72 4.6 5.41 PulmHT 5.64 5.33 5.23 
30 5.41 4.98 5.25 NPM 5.22 5.62 5.2 FED 
31 3.36 3.28 3.96 S.J. 4.15 4.06 3.69 6 months old 
32 3.67 3.49 3.75 TGA 4.47 4.81 4.5 4.74kg 
33 3.6 3.47 3.91 Switch Surgery 4.64 5.04 4.71 
34 9.67 9.62 8.31 4.8 5.13 5.22 
35 4.81 5.11 7.18 NPM 6.17 6.48 5.61 FED 
cNST = time-dependent factor corrected values 
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Data (b) In-vivo NST-NST (kPa) 
NST 1 NST2 PaC02 Patient NST 1 NST2 PaC02 
36 4.56 4.64 7.57 A.S. 5.75 5.36 7.65 3 months old 
37 5.63 5.89 7.87 ChLD 5.44 5.99 6.68 3.5kg 
38 6.29 6.24 7.06 RSV+ 4.37 3.86 6.38 
39 5.27 5.26 7.41 4.73 4.86 5.75 
40 5.98 6.13 8.2 NPM 6 6.14 6.34 FED 
41 9.12 8.71 12.2 K.I. 7.12 6.81 10 11 months old 
42 11.13 10.18 11.51 Pulm Dysplasia 7.67 7.05 7.33 5.5kg 
43 7.01 6.77 7.5 RSV+ 6.97 6.14 8.06 
44 6.6 6.63 8.7 8.71 8.34 8.92 
45 6.46 6.88 8.3 NPM 6.23 5.99 6.2 FED 
46 5.02 4.98 5.8 S.L. 4.18 4.34 6.35 3.5 months old 
47 4.93 5.02 4.74 Pneumonia 4.34 5.04 6.11 2.9kg 
48 4.54 4.86 4.9 PAPVD 5.55 4.77 6.42 
49 4.79 4.38 5.76 4.79 5.04 5.84 
50 4.74 4.7 5.4 NPM 4.28 4.34 5.46 FED 
cNST = time-dependent factor corrected values 
Page 2 
Data (c) In-vitro study (kPa) 
Paratrend RGT NST PBST cNST cPBST Bath 
2.53 2.3 1.56 2.48 1.76 2.75 2.07 
2.55 2.4 1.49 2.84 1.68 3.15 1.98 
2.5 2.3 1.47 2.46 1.66 2.73 1.99 
2.5 2.4 1.52 2.83 1.72 3.14 2.13 
2.49 2.4 1.48 2.52 1.67 2.80 2.11 
2.5 2.4 1.38 2.27 1.56 2.52 1.82 
2.52 2.4 1.51 2.36 1.71 2.62 1.98 
2.5 2.4 1.46 2.82 1.65 3.13 1.79 
2.51 2.4 1.42 2.83 1.60 3.14 2.08 
2.52 2.4 1.49 2.46 1.68 2.73 1.96 
2.49 2.3 1.44 2.54 1.63 2.82 2.08 
2.53 2.4 1.35 2.43 1.53 2.70 2.09 
2.52 2.4 1.37 2.74 1.55 3.04 2.01 
2.49 2.4 1.66 2.45 1.88 2.72 2.14 
2.48 2.4 1.72 2.71 1.94 3.01 2.18 
2.55 2.3 1.45 2.4 1.64 2.66 2.06 
2.5 2.3 1.5 2.6 1.70 2.89 2.07 
2.52 2.3 1.58 2.63 1.79 2.92 2.19 
2.52 2.3 1.46 2.36 1.65 2.62 2.04 
2.54 2.3 1.43 2.45 1.62 2.72 2.02 
4.99 4.6 2.88 4.16 3.25 4.62 3.46 
4.95 4.6 2.88 3.88 3.25 4.31 3.53 
4.98 4.7 2.89 4.05 3.27 4.50 3.56 
5.01 4.7 2.81 3.85 3.18 4.27 3.62 
4.98 4.7 3.05 4.36 3.45 4.84 3.38 
4.99 4.7 2.91 4.53 3.29 5.03 3.53 
5.05 4.6 2.82 4.19 3.19 4.65 3.49 
5.06 4.6 2.64 4.27 2.98 4.74 3.26 
5.02 4.6 2.56 4.29 2.89 4.76 3.24 
5.04 4.6 2.84 3.64 3.21 4.04 3.47 
4.98 4.6 2.78 4.72 3.14 5.24 3.22 
5.05 4.7 2.73 4.49 3.08 4.98 3.3 
5.02 4.7 2.68 4.43 3.03 4.92 3.34 
5.06 4.7 2.81 4.26 3.18 4.73 3.37 
5.02 4.6 2.66 3.97 3.01 4.41 3.4 
4.98 4.7 2.87 4.1 3.24 4.55 3.72 
5.01 4.7 3.04 4.18 3.44 4.64 3.46 
5 4.7 2.89 4.54 3.27 5.04 3.31 
5 4.8 2.58 3.93 2.92 4.36 3.48 
4.99 4.7 2.54 4.38 2.87 4.86 3.53 
cNST + cPBST = time-dependent factor corrected values 
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Data (c) In-vitro study (kPa) 
Paratrend RGT NST PBST cNST cPBST Bath 
7.48 7.2 3.97 6.19 4.49 6.87 5.04 
7.51 7.3 3.95 5.45 4.46 6.05 5.05 
7.52 7.3 4.21 6.42 4.76 7.13 4.61 
7.5 7.2 4.17 6.44 4.71 7.15 4.95 
7.5 7.2 3.83 6.13 4.33 6.80 4.97 
7.46 7.2 3.84 5.77 4.34 6.40 4.77 
7.48 7.2 4.27 5.84 4.83 6.48 4.86 
7.47 7.2 4.16 6.06 4.70 6.73 4.91 
7.51 7.2 4.24 5.96 4.79 6.62 4.95 
7.49 7.2 4.1 5.88 4.63 6.53 4.69 
7.52 7.1 4.39 5.79 4.96 6.43 4.88 
7.53 7.1 3.98 5.86 4.50 6.50 4.76 
7.54 7.1 4.03 5.67 4.55 6.29 4.77 
7.55 7 4.08 6.02 4.61 6.68 4.79 
7.5 7.1 4.14 5.51 4.68 6.12 4.99 
7.5 7 3.82 5.4 4.32 5.99 4.92 
7.55 7 4.13 5.47 4.67 6.07 4.86 
7.5 7.1 4.36 6.26 4.93 6.95 4.74 
7.56 7.1 3.97 6.15 4.49 6.83 4.44 
7.52 7 3.81 5.79 4.31 6.43 4.77 
10 9.7 5.85 8.54 6.61 9.48 6.2 
9.97 9.7 5.41 8.49 6.11 9.42 6.63 
9.96 9.7 5.67 7.88 6.41 8.75 6.89 
10 9.7 5.73 8.52 6.47 9.46 6.7 
9.97 9.7 5.83 7.63 6.59 8.47 6.41 
9.98 9.7 5.34 7.96 6.03 8.84 6.34 
10 9.7 5.33 8.13 6.02 9.02 6.67 
10 9.7 5.56 7.28 6.28 8.08 6.63 
9.99 9.7 5.59 8.03 6.32 8.91 6.59 
10 9.7 5.68 7.64 6.42 8.48 6.34 
10.1 9.5 5.26 7.87 5.94 8.74 6.45 
10.1 9.5 5.25 7.75 5.93 8.60 6.25 
10.1 9.6 5.51 7.73 6.23 8.58 6.21 
10 9.5 5.69 8.01 6.43 8.89 6.36 
10 9.6 5.51 7.07 6.23 7.85 5.89 
9.99 9.6 5.26 7.17 5.94 7.96 6.3 
10 9.6 4.96 7.62 5.60 8.46 5.52 
9.99 9.6 4.78 7.31 5.40 8.11 5.46 
10 9.6 5.24 8.17 5.92 9.07 5.93 
10.1 9.6 5.39 8.01 6.09 8.89 6.43 
cNST + cPBST = time-dependent factor corrected values 
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